If it is a blinded trial then the lack of details and certainty of final info does make sense. The opacity is deliberate and should be so. The fact that the trial results are being being analysed and will be reported when complete is actually good news that will surface when it is ready - and will probably be pretty beneficial to the company.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)